Bio-Connect
GTX102170 WB Image
GTX102170 WB Image
GTX102170 WB Image

FOXM1 antibody

Research Use Only
GTX102170
GeneTex
Product group Antibodies
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    FOXM1 antibody
  • Delivery Days Customer
    9
  • Certification
    Research Use Only
  • Concentration
    1.97 mg/ml
  • Isotype
    IgG
  • Storage Instruction
    2°C to 8°C,-20°C
  • UNSPSC
    12352203

References

  • Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas. Zeng WJ et al., 2020 Sep, J Cell Mol Med
    Read more
  • CDC20 maintains tumor initiating cells. Xie Q et al., 2015 May 30, Oncotarget
    Read more
  • Chromatin associated SETD3 negatively regulates VEGF expression. Cohn O et al., 2016 Nov 15, Sci Rep
    Read more
  • Co-regulation of the antagonistic RepoMan:Aurora-B pair in proliferating cells. Manzione MG et al., 2020 Mar 15, Mol Biol Cell
    Read more
  • FOXM1 binds directly to non-consensus sequences in the human genome. Sanders DA et al., 2015 Jun 23, Genome Biol
    Read more
  • FoxM1 Induced Paclitaxel Resistance via Activation of the FoxM1/PHB1/RAF-MEK-ERK Pathway and Enhancement of the ABCA2 Transporter. Huang C et al., 2019 Sep 27, Mol Ther Oncolytics
    Read more
  • Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells. Sanders DA et al., 2013 Jan 24, Genome Biol
    Read more
  • Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer. Kyuno T et al., 2020 Feb, Pancreas
    Read more
  • KIAA0101 is a novel transcriptional target of FoxM1 and is involved in the regulation of hepatocellular carcinoma microvascular invasion by regulating epithelial-mesenchymal transition. Zhang T et al., 2019, J Cancer
    Read more
  • Niclosamide exerts anticancer effects through inhibition of the FOXM1-mediated DNA damage response in prostate cancer. Kim MY et al., 2021, Am J Cancer Res
    Read more